These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7525116)

  • 21. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
    Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
    Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of prostate-specific antigen in serum using four different immunoassays.
    Cattini R; Robinson D; Gill O; Jolley N; Bacarese-Hamilton T
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):181-5. PubMed ID: 7518258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population.
    Roehrborn CG; Pickens GJ; Carmody T
    Urology; 1996 Jan; 47(1):59-66. PubMed ID: 8560664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical evaluation of the new Prostatus PSA Free/Total assay for prostate-specific antigen as part of a screening study for prostate cancer.
    Blijenberg BG; Bangma CH; Kranse R; Eman I; Schröder FH
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):111-4. PubMed ID: 9056753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigen.
    Jacobsen SJ; Lilja H; Klee GG; Wright GL; Pettersson K; Oesterling JE
    Urology; 1994 Oct; 44(4):512-8. PubMed ID: 7524236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological variation of prostate specific antigen levels in serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients.
    Nixon RG; Wener MH; Smith KM; Parson RE; Strobel SA; Brawer MK
    J Urol; 1997 Jun; 157(6):2183-90. PubMed ID: 9146611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of prostate-specific antigen in serum by immunoradiometric assay.
    Lindstedt G; Jacobsson A; Lundberg PA; Hedelin H; Pettersson S; Unsgaard B
    Clin Chem; 1990 Jan; 36(1):53-8. PubMed ID: 1688745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancer.
    Oberpenning F; Weining C; Brandt B; De Angelis G; Heinecke A; Hamm M; Stieber P; Hertle L; Schmid HP; Semjonow A
    Clin Chem Lab Med; 2003 Jan; 41(1):90-4. PubMed ID: 12636056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges.
    Meshref AW; Bazinet M; Trudel C; Aronson S; Peloquin F; Nachabe M; Dessureault J; Aprikian AG; Begin LR; Elhilali MM
    Urology; 1995 Jun; 45(6):972-9. PubMed ID: 7539562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy.
    Prestigiacomo AF; Stamey TA
    J Urol; 1994 Nov; 152(5 Pt 1):1515-9. PubMed ID: 7523709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleic acid detection immunoassay for prostate-specific antigen based on immuno-PCR methodology.
    McDermed JE; Sanders R; Fait S; Klem RE; Sarno MJ; Adams TH; Diamandis EP
    Clin Chem; 2012 Apr; 58(4):732-40. PubMed ID: 22361936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supersensitive PSA-analysis after radical prostatectomy: a powerful tool to reduce the time gap between surgery and evidence of biochemical failure.
    Haese A; Huland E; Graefen M; Huland H
    Anticancer Res; 1999; 19(4A):2641-4. PubMed ID: 10470210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of residual prostate cancer after radical prostatectomy with the Abbott IMx PSA assay.
    Schild SE; Wong WW; Novicki DE; Ferrigni RG; Swanson SK
    Urology; 1996 Jun; 47(6):878-81. PubMed ID: 8677580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possibility of improving the acceptance rateof early detection testing for prostate cancerwith a one-step test for prostate-specific antigen in whole blood.
    Berg W; Linder C; Eschholz G; Link S; Schubert J
    Urol Int; 1999; 63(2):102-6. PubMed ID: 10592497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical performance of the Tandem-R free PSA immunoassay measuring free prostate-specific antigen.
    Woodrum DL; French CM; Hill TM; Roman SJ; Slatore HL; Shaffer JL; York LG; Eure KL; Loveland KG; Gasior GH; Southwick PC; Shamel LB
    Clin Chem; 1997 Jul; 43(7):1203-8. PubMed ID: 9216457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in measurement of prostate-specific antigen: importance of method and lot variability.
    Wener MH; Daum PR; Brawer MK
    Clin Chem; 1995 Dec; 41(12 Pt 1):1730-7. PubMed ID: 7497613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partly nonparametric approach for determining the limit of detection.
    Linnet K; Kondratovich M
    Clin Chem; 2004 Apr; 50(4):732-40. PubMed ID: 14764644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical performance and clinical validity of two free prostate-specific antigen assays compared.
    Jung K; Stephan C; Lein M; Henke W; Schnorr D; Brux B; Schürenkämper P; Loening SA
    Clin Chem; 1996 Jul; 42(7):1026-33. PubMed ID: 8674185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermethod differences in results for total PSA, free PSA, and percentage of free PSA.
    Slev PR; La'ulu SL; Roberts WL
    Am J Clin Pathol; 2008 Jun; 129(6):952-8. PubMed ID: 18480013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Evaluation of an Immunoglobulin Y-Based ELISA for Measuring Prostate Specific Antigen in Human Serum.
    Łupicka-Słowik A; Grzywa R; Leporowska E; Procyk D; Oleksyszyn J; Sieńczyk M
    Ann Lab Med; 2019 Jul; 39(4):373-380. PubMed ID: 30809983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.